{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Dosing regimen of avelumab for the treatment of cancer", "item": "https://www.patentleaderboard.com/patent/11274154"}]}

Home › Dosing regimen of avelumab for the treatment of cancer

Dosing regimen of avelumab for the treatment of cancer

US Patent 11274154 · Granted Mar 15, 2022

Estimated economic value: $2,178,784,000 ⓘ

Assignee

Pfizer
Merck

Inventors

Glen Ian Andrews (2 patents)
Carlo Leonel BELLO (1 patents)
Satjit Singh BRAR (1 patents)
Shaonan WANG (3 patents)
Pascal GIRARD (1 patents)

View full patent text on Google Patents →